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In this study, we show that reactive oxygen species production
induced by tumour necrosis factor a (TNF-a) in L929 cells
was associated with a decrease in the steady-state mRNA levels
of the mitochondrial transcript ATPase 6-8. Simultaneously,
the transcript levels of two nuclear-encoded glycolytic enzymes,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
phosphofructokinase, were increased. These changes were
associated with decreased protein levels of the ATPase subunit a
(encoded by the mitochondrial ATPase 6 gene) and cytochrome
c oxidase subunit II, and increased protein levels of phospho-
fructokinase. Since TNF-a had no effect on the amount of
mitochondrial DNA, the results suggested that TNF-a acted at
INTRODUCTION
Tumour necrosis factor a (TNF-a) is a cytokine, produced
mainly by activated macrophages [1], with cytotoxic effects
against certain tumour cells [2]. Although these effects have been
studied extensively, the molecular mechanism of action of
TNF-a is not well understood [3,4]. Previous investigations have
shown contradictory results regarding whether TNF-a-induced
cytotoxicity occurs through necrosis or apoptosis [3]. Recent
results indicate that TNF-a induces necrosis in L929 cells,
although apoptosis-like features have also been observed [5,6].
Regardless of the mode of cell death, however, it has been shown
that TNF-a-induced cytotoxicity of L929 cells is mediated by
mitochondrial formation of reactive oxygen species (ROS) [5–9].
The reported ability of antioxidants to protect cells against
TNF-a cytotoxicity supports this hypothesis [7,10]. Exposing
cells to oxidative stress can result in severe metabolic dysfunction,
including the peroxidation of lipid membranes [11], an increase
of cytosolic Ca#+ [12], induction of mitochondrial inner-
membrane permeability transition [13] and DNA damage [14,15].
In cells exposed to oxidative stress, there are two primary effects :
direct molecular damage, such as lipid peroxidation, and in-
duction of protective systems that repair and protect the cell
against additional damage [16–18]. The latter response includes
both antioxidant enzymes and damage-removal and -repair
systems for oxidatively damaged lipids, proteins and DNA.
Abbreviations used: BHA, butylated hydroxianisole ; BHT, butylated hydroxytoluene; COX II, cytochrome c oxidase, subunit II ; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; MnSOD, manganese superoxide dismutase ; mtDNA, mitochondrial DNA; PFK, phosphofructokinase;
PI, propidium iodide; R123, Rhodamine 123; ROS, reactive oxygen species ; TCA, tricarboxylic acid ; TMPD, tetramethyl-p-phenylenediamine; TNF-a,
tumour necrosis factor a ; TSP, sodium 3-trimethylsilyl-(2,2,3,3-2H4)-propionate.
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the transcriptional and}or post-transcriptional level. Reactive
oxygen species scavengers, such as butylated hydroxianisole and
butylated hydroxytoluene, blocked the production of free
radicals, prevented the down-regulation of ATPase 6-8 tran-
scripts, preserved the protein levels of ATPase subunit a and
cytochrome c oxidase subunit II, and attenuated the cytotoxic
response to TNF-a, indicating a direct link between these two
phenomena.
Key words: ATPase 6-8, free radical, glycolysis, mitochondrial
transcript, necrosis, tumour necrosis factor a (TNF-a).
Mitochondria have been found to be especially sensitive to
oxidative damage. Release of calcium, depletion of ATP, lipid
peroxidation, protein oxidation, DNA damage and loss of
electron-transport capacity have all been reported [13,19–24].
Several lines of evidence also suggest that oxidative stress
decreases mitochondrial transcription and steady-state levels of
mitochondrial RNAs [25–28]. Modulation of mitochondrial
expression by free radicals is not limited to RNA, as certain
mitochondrial proteins are also specifically degraded in response
to oxidative stress [20].
The objective of this study was to investigate the effects of
TNF-a-mediated free radical production on mitochondrial tran-
scripts and protein levels in L929 cells, and to determine its
relationship with cell death. We show here that ROS production
induced by TNF-a in L929 cells was associated with a decrease
in the steady-state mRNA levels of the mitochondrial transcript
ATPase 6-8 in a time-dependent manner. Simultaneously, the
transcript levels of two nuclear-encoded glycolytic enzymes,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
phosphofructokinase (PFK), were increased. These changes were
associated with decreased levels of the mitochondrial DNA
(mtDNA)-encoded proteins ATPase subunit a (encoded by the
mitochondrial ATPase 6 gene) and cytochrome c oxidase, subunit
II (COX II), and increased protein levels of PFK. Furthermore,
ROS scavengers such as butylated hydroxianisole (BHA) and
butylated hydroxytoluene (BHT) blocked the production of free
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radicals, prevented the down-regulation of ATPase 6-8
transcripts, and ATPase subunit a and COX II protein levels,
and attenuated the cytotoxic response to TNF-a. These results
indicate that down-regulation of mitochondrial proteins by free
radicals might be implicated in TNF-a-mediated cytotoxicity in
L929 cells.
EXPERIMENTAL
Materials
Recombinant human TNF-a was purchased from Genzyme Co.
(Cambridge, MA, U.S.A.). RPMI-1640 medium was from
Biochrom (Berlin, Germany). Propidium iodide (PI) and trypsin
were purchased from Sigma (Alcobendas, Madrid, Spain).
Dihydrorhodamine 123, Hoechst 33342, anti-cytochrome c oxi-
dase (subunit II), anti-ubiquinol-cytochrome c oxidoreductase
subunit core 2, anti-ATPase a antibodies and high-fluorescence
FITC-labelled goat anti-mouse antibodies were purchased from
Molecular Probes (Eugene, OR, U.S.A.). Anti-PFK antibodies
were from Biodesign International (Saco, ME, U.S.A.). Anti-
cytochrome c antibodies (7H8.2C12 and 6H2.B4) were purchased
from BD PharMingen (San Diego, CA, U.S.A.). Anti-GAPDH
monoclonal antibody, clone 6C5, was purchased from Research
Diagnostic (Flanders, NJ, U.S.A.). A cocktail of protease
inhibitors (complete cocktail) was purchased from Roche Bio-
chemicals (Indianapolis, IN, U.S.A.). The ECL Western blotting
analysis system was from Amersham Biosciences (Little Chalfont,
Bucks., U.K.). Anti-manganese superoxide dismutase (MnSOD)
antibodies were a gift from Dr Jose A. Melendez (Albany
Medical College, Albany, NY, U.S.A.). PFK cDNA was a gift
from Dr Juan J. Arago! n (Universidad Auto! noma de Madrid,
Madrid, Spain). 18 S rDNA was a gift from Dr Michael P. King
(Thomas Jefferson University, Philadelphia, PA, U.S.A.). Anti-
ATPase 6 (subunit a) antibodies and the clone pAM I were a gift
from Dr David A Clayton (Stanford University, Stanford, CA,
U.S.A.).
Cell cultures
Cells from the murine fibrosarcoma cell line L929 (American
Type Culture Collection, Rockville, MD, U.S.A.) were grown in
RPMI-1640 medium supplemented with 10% heat-inactivated
fetal calf serum, 2 mM glutamine, penicillin (100 units}ml) and
streptomycin (0.1 mg}ml) in a humidified incubator in 5% CO
#
in air, at 37 °C.
Separation of viable and dead cells
During the process of cell death, L929 cells detached from the
flask and floated in the medium. In this study, we exploited this
phenomenon as an easy way to separate attached}living cells and
floating}dead cells. Thus, after various incubation times, the
medium containing the non-adherent cells was removed and
the cells collected if needed. The monolayer of attached cells was
then washed with PBS and incubated with trypsin for 5 min at
37 °C to remove the cells from the flask. Viability of floating and
attached cells was determined by PI staining and microscopic
visualization. Only samples of attached cells that contained
" 85% viable cells were used for further studies. The floating
cell population was 100% PI-positive.
Cytotoxicity assays
Cytotoxicity was measured using lactate dehydrogenase leakage
from damaged cells and was expressed as a percentage of total
cellular lactate dehydrogenase activity, as described by Decker
and Lohmann-Matthes [29]. Lactate dehydrogenase activity was
measured using a commercial assay kit (Cromatest ; Laboratorios
Knickerbocker, Barcelona, Spain).
Cytochrome c oxidase activity
Cells were treated with TNF-a for 72 h. At this time, the
attached cells were harvested, centrifuged and resuspended in
respiration buffer (0.25 M sucrose, 0.1% BSA, 10 mM MgCl
#
,
10 mM K+Hepes and 5 mM KH
#
PO
%
, pH 7.2) at a final
concentration of 2‹10( cells}ml. An aliquot (0.5 ml) of the
suspension was injected into a chamber containing 3.5 ml of
air-saturated respiration buffer and 1 mM ADP at 37 °C. The
cells were permeabilized with digitonin (final concentration,
0.005%), and substrates and inhibitors were added in the
following order and final concentrations : 50 nM antimycin A,
1 mM ascorbate and 0.4 mM tetramethyl-p-phenylenediamine
(TMPD). Antimycin A was used to inhibit autologous mito-
chondrial electron transport. TMPD is an electron donor that
reduces cytochrome c non-enzymically. Therefore, when TMPD
is used as a substrate, changes inO
#
-uptake rates reflect changes in
cytochrome c oxidase activity. Ascorbate was used to reduce
TMPD. Oxygen concentration was calibrated with air-saturated
buffer, assuming 390 ng-atoms of oxygen}ml of buffer. Rates of
potassium cyanide-sensitive oxygen consumption are expressed
as ng-atoms of oxygen}min per 1‹10( cells.
Glutamine oxidation
L929 cells were treated with TNF-a for 72 h. After removing the
medium and the floating dead cells, the attached cells were
incubated in 5 ml of RPMI-1640 containing 2 mM glutamine
and 0.5 lCi of l-[U-"%C]glutamine (DuPont-New England Nu-
clear, Boston, MA, U.S.A.) with a specific activity of 216 mCi}
mmol. Then 0.2 ml of 6 M KOH was injected into the central
wells to trap CO
#
. These were small plastic wells situated inside
the flasks and above the level of the incubation medium. Flasks
were sealed with stoppers and incubated at 37 °C for 3 h. CO
#
evolved during the incubation was trapped by the central wells.
Incubation was stopped by adding 0.2 ml of 2 M perchloric acid
through the rubber cap into the flasks. After 2 h, the central wells
were transferred to plastic scintillation vials containing 1 ml of
water and 15 ml of scintillation fluid and placed in a scintillation
counter for radioactivity measurements. Results are expressed
as c.p.m.}10’ cells.
ATP assay
Cellular content of ATP in the attached}living population were
measured in trichloroacetic acid (10%, w}v)-precipitated samples
using the luciferin}luciferase reaction with an ATP bio-
luminescent assay kit (Sigma). Luminescence was measured in a
bioluminometer equipped with an injector (Lumat LB 9501;
Berthold).
Cell extracts and NMR spectroscopy
Cell extracts were prepared from 60‹10’ attached}living L929
cells. Harvested cells were centrifuged at 4 °C three times in
Hepes-buffered Hanks’s balanced salt solution containing 0.1%
(w}v) dextrose. The cell pellet was treated with five vol. of cold
trichloroacetic acid 10% (w}v), followed by sonication on ice for
5 min. The extract was neutralized by 4 M KOH, the mixture
was centrifuged for 30 min at 15000 g (4 °C) and the supernatant
was lyophilized and stored at fi80 °C. For NMR measurements,
the dried homogenate was dissolved in 0.7 ml of #H
#
O in a 5 mm
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NMR tube. The pH was adjusted with #HCl to pH 7.4. High-
resolution "H-NMR spectra were obtained at 500 MHz using a
vertical superconducting narrow-bore Bruker DBX-500 spec-
trometer (Ettlingen, Germany). The magnetic field homogeneity
was optimized by an automatic shimming programme, and water
linewidths of typically 3 Hz were obtained. Spectra were collected
using presaturation at the frequency of the residual proton}
deuterium oxide (HOD) peak followed by a 45° flip angle pulse,
with an interpulse time of 3.5 s for full relaxation of all the
resonances. Scans (128) were accumulated for each cell extract
spectrum. Proton spectra were standardized by referencing to
TSP [sodium 3-trimethylsilyl-(2,2,3,3-#H
%
)-propionate]. The
spectra were analysed on a personal computer running com-
mercial Bruker Win-NMR software. The data were zero-filled,
line broadened and then Fourier-transformed. Zero-order
phasing and baseline correction was performed. We measured
peak areas with the same software under the interactive decon-
volution package. Initial starting values for the peaks were
defined manually and then fitted automatically with Lorentzian
lines. Quantitative analysis of identified peaks was carried out by
calculating peak-height ratios relative to TSP.
Glucose and lactate determinations
Glucose and lactate concentrations in the medium from control
and TNF-a-treated cells were measured using commercial assay
kits (Sigma).
Northern blot analysis
RNA was isolated from the attached}living cells by the phenol}
chloroform extraction method of White and Bancroft [30]. Total
RNA (10 lg) was electrophoresed in a 1% agarose}2.2 M
formaldehyde gel in 20 mM Mopso [3-(N-morpholino)-2-
hydroxypropanesulphonic acid] buffer, pH 7.0. RNA samples
were stained with ethidium bromide and transferred overnight by
capillary blotting in 20‹SSC (where 1‹SSC is 0.15 M NaCl}
0.015 M sodium citrate) to nylon membranes. The RNA was
UV-crosslinked to the membranes and prehybridized at 65 °C in
7% SDS plus 0.5 M phosphate buffer (pH 7.0) and 50 lg}ml
sonicated salmon sperm DNA. The nylon membranes were
hybridized overnight at 65 °C in freshly prepared hybridization
solution with addition of 1‹10’ c.p.m.}ml of the labelled cDNA
probe. The nylon membranes were washed at a stringency of
2‹SSC}0.1% SDS at 65 °C for 15 min and exposed to X-ray
film at fi70 °C with an intensifying screen. The radiograms were
quantified by scanning laser densitometry (Desk TopTM Scanner
Plus; Amersham Biosciences) and the absorbances of each
specific signal were normalized with the corresponding value
obtained for the 18 S rDNA.
ATPase 6 probe generation
A specific DNA fragment covering most of the ATPase 6 gene
was excised from pAM I and cloned into the pBluescript vector
(Stratagene, La Jolla, CA, U.S.A.) by standard techniques.
DNA slot-blot analysis
Different amounts of total DNA from control and TNF-a-
treated cells for 72 h were blotted to a Zeta-probe membrane
using the Manifold II System (Schleicher & Schuell) and fixed to
the filter according to the manufacturer’s instructions. To
quantify the mtDNA, filters were probed at high stringency with
an [a-$#P]dCTP-labelled mouse pAM I (entire mouse mtDNA)
probe. After several washes with 0.1% SDS}0.1‹SSC at 68 °C
the filter was autoradiographed.
Measurement of intracellular generation of ROS
Flow-cytometric analysis of the intracellular generation of ROS
was performed using dihydrorhodamine 123 as a probe. Cells
were cultured in six-well plates (35 mm diameter well) and, at
confluence (1‹10’ cells}plate), were treated with TNF-a
(25 ng}ml). After the indicated incubation times, dihydro-
rhodamine 123 (1 lM) was added and the incubation was
prolonged for 30 min. Once the incubation was finished, cells
were harvested, washed, centrifuged (200 g), resuspended in
RPMI-1640 medium and analysed by flow cytometry (excitation
at 488 nm and fluorescence detection at 530 nm). Rhodamine
123 (R123) fluorescence was analysed in viable cells characterized
by forward scatter versus side scatter.
Measurement of cellular glutathione
Cellular glutathione on attached}living cells was measured using
Eady et al.’s modification [31] of Tietze’s assay [32], based on the
principle that reduced glutathione can be measured by an enzymic
recycling procedure in which it is sequentially oxidized by 5,5«-
dithiobis-(2-nitrobenzoic acid) and reduced by NADPH in the
presence of glutathione reductase. The rate of formation of
2-nitro-5-thiobenzoic acid can be followed using a spectro-
photometer and reduced glutathione quantified by reference to a
standard curve.
Western blot analysis
Cytosolic and mitochondrial fractions from control and TNF-a-
treated cells were prepared as described in [33]. Floating and
attached L929 cells were collected separately, washed twice with
ice-cold PBS, pH 7.4, followed by centrifugation at 200 g for
5 min. The cell pellet was then resuspended in 600 ll of extraction
buffer containing 220 mM mannitol, 68 mM sucrose, 50 mM
Pipes}KOH, pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl
#
,
1 mM dithiothreitol and protease inhibitors (Complete Cocktail ;
Roche Biochemicals). After 30 min of incubation on ice, cells
were homogenized with a Teflon homogenizer (3 min, 300 rev.}
min). Cell homogenates were spun at 14000 g for 15 min and
supernatants were removed and stored at fi70 °C, until analysis
by gel electrophoresis. The quality of the cytosolic fraction was
routinely monitored by Western blotting for COX II for potential
mitochondrial contamination. The quality of the mitochondrial
fraction was monitored routinely by Western blotting for
GAPDH for potential cytosolic contamination. From whole
lysates (50 lg), cytosolic or mitochondrial proteins were
separated on a 5 or 12% denaturing SDS}PAGE minigel.
Primary antibodies were diluted 1:1000. The membrane was
then incubated with the corresponding secondary antibody
coupled to horseradish peroxidase at a 1:10000 dilution. The
specific protein complexes were identified using the ECL Western
blotting analysis system.
Cytochrome c immunocytochemistry
L929 cells were grown on 1 mm glass coverslips (Goldseal No. 1)
for 24–48 h in RPMI-1640 containing 10% fetal bovine serum.
Cells were then treated with TNF-a for 72 h. To differentiate
between live and dead cells, the ‘Dead Red’ reagent (Molecular
Probes) was added to the cells 10 min before fixation. For
immunostaining cells were fixed in 3.8% paraformaldehyde
for 5 min at room temperature, permeabilized in 0.1%
saponin for 5 min and stained with anti-cytochrome c antibodies
(6H2.B4) diluted 1:100 in PBS for 1–2 h at 37 °C in a humidified
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chamber. Excess antibody binding was removed by washing
the coverslips with PBS three times for 5 min each. The
secondary antibody, a high-fluorescence FITC-labelled goat anti-
mouse antibody, diluted 1:100 in PBS, was added and incubated
for 1 h 37 °C. Coverslips were then rinsed with PBS for 3 min,
incubated for 1 min with PBS containing Hoechst 33342
(1 lg}ml) and washed with PBS three times for 5 min each.
Finally, the coverslips were mounted on to microscope slides
using Vectashield mounting medium (Vector Laboratories,
Burlingame, CA, U.S.A.) and analysed using an Olympus BX40
fluorescent microscope using a ‹1000 final magnification.
Statistical analysis
All results are expressed as means‡S.D. unless stated otherwise.
Unpaired Student’s t tests were used to evaluate the significance
of differences between groups, accepting P! 0.05 as the level of
significance.
RESULTS
Treatment with TNF-a alone induces a necrosis-like mode of
death in L929 cells
The L929 mouse fibrosarcoma cell line is commonly used to test
the cytotoxic effects of TNF-a [34–37]. However, contradictory
Figure 1 TNF-a induces necrosis in L929 cells
Immunolocalization of cytochrome c (Cyt C), plasma membrane permeability (Dead Red) and nuclear morphology (Hoechst) are shown in control and TNF-a-treated L929 cells (floating and attached
cells). Cells were grown on glass coverslips and treated with 25 ng/ml TNF-a for 72 h, fixed and immunostained with anti-cytochrome c monoclonal antibodies (clone 7H8C12) as described in
the Experimental section. Jurkat cells treated with camptothecin (10 lM) were used as a positive control for apoptosis.
reports exist regarding the kind of cell death induced by TNF-a
in L929 cells. Previously, we have shown that TNF-a in the
presence of cycloheximide induces in L929 cells a kind of cell
death with many features of the apoptotic programme: mem-
brane blebbing, cytochrome c release, caspase activation,
chromatin condensation and nuclear fragmentation [38]. To
ascertain whether L929 cells treated with TNF-a alone underwent
apoptosis or necrosis, we examined cytochrome c release, nuclear
morphology and plasma membrane integrity in control and
TNF-a-treated cells for 72 h. To check plasma membrane
integrity, we used the Dead Red dye, which is a cell-impermeant
red fluorescent nucleic acid stain that labels only cells with a
disrupted membrane [39]. By using this stain, viability staining
can take place before fixation without altering the distinctive
immunofluorescence-staining pattern. Untreated L929 cells
showed intact plasma membranes, a punctuate pattern for
cytochrome c, consistent with its mitochondrial localization, and
uniformly stained nuclei (Figure 1). In TNF-a-treated cells, we
analysed both the attached}living cells and the floating}dead
cells. In the attached}living population, the cells showed intact
plasma membranes, a punctuate pattern for cytochrome c and
uniformly stained nuclei. In contrast, the floating}dead cells
showed disruption of the plasma membrane, the almost complete
disappearance of cytochrome c staining and the presence of
relatively intact nuclei. Jurkat cells that undergo extensive
# 2003 Biochemical Society
613Tumour necrosis factor a and mitochondrial transcripts
A
B
C
Figure 2 Effect of TNF-a on cellular viability, intracellular generation of
ROS and glutathione levels
Cells were incubated in the absence or presence of 25 ng/ml TNF-a for 24, 48 and 72 h.
(A) Cell viability was examined as described in the Experimental section. (B) Cellular generation
of ROS was determined by flow cytometry using R123 fluorescence. (C) Effect of TNF-a on the
intracellular concentration of glutathione. Results are means‡S.D. from three independent
experiments. *P ! 0.01, **P ! 0.001 between control and treated cells. In (A) and (C), data
represent the percentage increase or decrease with respect to controls.
apoptotic cell death in response to camptothecin were used as a
positive control for apoptosis. As seen in Figure 1, Jurkat cells
treated with camptothecin showed a diffuse pattern of cyto-
chrome c staining, consistent with its release into the cytoplasm,
chromatin condensation and nuclear fragmentation, all in the
presence of intact plasma membranes. These observations suggest
that the treatment with TNF-a alone induced necrotic cell death
in L929 cells.
TNF-a induces cell death and free radical production in L929
cells
It has been reported that TNF-a-induced cytotoxicity in L929
cells is caused by the induced ROS production in mitochon-
dria [7]. Therefore, we examined cell death and ROS levels in
control and TNF-a-treated L929 cells. Figure 2(A) shows that
murine L929 cells are susceptible to the cytotoxic action of
A
B
Figure 3 TNF-a regulation of both mitochondrial and nuclear gene
expression in L929 cells
(A) Total RNA (10 lg/lane) isolated from control and TNF-a-treated L929 cells cultured for 8,
12, 16, 24, 48 and 72 h was analysed by Northern hybridization using radiolabelled ATPase
6-8, GAPDH and PFK cDNA probes. Control for RNA loading and integrity was assessed by
probing with 18 S rDNA. Representative radiograms are shown ; C, control ; T, TNF-a. (B) Total
RNA (10 lg/lane) isolated from control and TNF-a-treated L929 cells cultured for 72 h, was
analysed by Northern hybridization using the radiolabelled pAM I probe. A representative
radiogram is shown.
TNF-a. TNF-a caused a 50% loss of viability after 72 h of treat-
ment. To examine the role of free radicals in TNF-a-induced
cytotoxicity, the intracellular generation ofROS by cultured L929
cells in response to TNF-a treatment was measured by flow
cytometry using the dihydrorhodamine 123 probe. As shown in
Figure 2(B), treatment of cells with 25 ng}ml TNF-a for 48 and
72 h resulted in a significant increase in R123 fluorescence,
indicating ROS generation. To investigate the antioxidant
reserves under TNF-a treatment, we analysed the levels of
glutathione. TNF-a treatment for 24, 48 and 72 h resulted in a
significant decrease in total glutathione (Figure 2C), suggesting
that TNF-a-induced ROS production was overcoming the
cellular defence against free radicals.
Effects of TNF-a on mitochondrial and nuclear mRNA levels
There is compelling evidence suggesting that oxidative stress can
modulate the levels of both mRNA and proteins in target cells
[22,40]. To examine whether the steady-state levels of mito-
chondrial and nuclear transcripts were affected by TNF-a-
induced free radicals, we studied the effects of TNF-a on the
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A
B
C
Figure 4 Effect of TNF-a in the content of ATPase 6-8, GAPDH and PFK
mRNA in L929 cells
RNA levels were determined by densitometric analysis of three different Northerns blots. The
hybridization signals were quantified by laser scanning and normalized to the 18 S rDNA
signal. Results are expressed as mean‡S.D. *P ! 0.01 and **P ! 0.001 between control
and treated cells.
expression of the mitochondrial gene ATPase 6 and the nuclear
genes GAPDH and PFK by Northern blot analysis. The ATPase
6 mRNA was detected as the bicistronic mRNA ATPase 6-8
coding for theATPase 6 andATPase 8 proteins. TNF-a treatment
had a biphasic effect on mRNA expression levels (Figures 3A
and 4). During the first 24 h of treatment, TNF-a induced a
slight increase in ATP 6-8, GAPDH and PFK mRNA steady-
state levels. In a second phase, starting at 48 h, coinciding with
ROS generation and the onset of cell death, TNF-a markedly
diminished the steady-state levels of the mitochondrial ATPase
6-8 mRNA, whereas it induced a dramatic increase of the nuclear
transcripts for GAPDH and PFK.
To determine whether TNF-a had a more general effect on the
mRNAs encoded by the mtDNA, we performed Northern Blot
analysis of control and TNF-a-treated L929 cells using as a
probe the entire mitochondrial genome (probe pAM I). As
shown in Figure 3(B), the treatment with TNF-a induced a
significant decrease in all the mitochondrial transcripts detected
by the pAM I probe, suggesting that TNF-a had a more general
effect on the steady-state levels of mitochondrial transcripts.
Figure 5 Effect of TNF-a on mtDNA content in L929 cells
Different amounts of DNA isolated from control (C) or TNF-a-treated cells for 72 h were loaded
on to nylon membranes and hybridized with pAM I as described in the Experimental section.
Figure 6 Effect of TNF-a on mitochondrial protein levels
Proteins from mitochondrial extracts of L929 cells exposed to TNF-a (25 ng/ml) for 24, 48 and
72 h, were separated by SDS/PAGE (10% gel) and immunostained with antibodies against
ATPase subunits a and a, cytochrome c oxidase (COX) subunits II and IV, ubiquinol-cyto-
chrome c oxidoreductase subunit core 2, MnSOD and cytochrome c.
Effects of TNF-a on mtDNA content in L929 cells
To investigate whether the decrease in ATPase 6-8 mRNA
observed in L929-treated cells was due to a reduction in the
number of mitochondria per cell, we examined the effects of
TNF-a on mtDNA content in L929 cells. Total DNA isolated
from L929 control and TNF-a-treated cells was probed with the
entire mitochondrial genome (probe pAM I). As shown in Fig-
ure 5, the amount of mtDNA was unaltered despite the observed
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A
B
Figure 7 Effect of TNF-a on protein levels of glycolytic enzymes
(A) Proteins from cytosolic extracts of L929 cells exposed to TNF-a (25 ng/ml) for 24, 48 and
72 h were separated by SDS/PAGE (10% gel) and immunostained with antibodies against
GAPDH and PFK. Actin antibodies were used to check for equal loading. (B) Densitometric
scanning of GAPDH and PFK expression in cytosols of L929 cells after TNF-a treatment.
Results are expressed as means‡S.D. from three independent experiments. *P ! 0.001
between control and treated cells.
changes in mitochondrial transcripts, indicating that mito-
chondrial gene expression is regulated by TNF-a at the level of
transcription and}or RNA stabilization and not by gene dosage.
Effects of TNF-a on protein levels
Having shown that TNF-a decreased mitochondrial mRNA
levels and increased the mRNA levels of two key enzymes in the
glycolytic pathway, we next determined whether these alterations
were also reflected at the protein level. Thus we examined the
protein levels of several mitochondrial proteins encoded by
either the mitochondrial or the nuclear DNA, and the cytosolic
GAPDH and PFK, encoded by the nuclear DNA.
Western blot analysis of the mitochondrial fraction from
control and TNF-a-treated L929 cells revealed that TNF-a
A
B
C
Figure 8 Effects of TNF-a on mitochondrial respiratory chain and glycolysis
rate
(A) Effect of TNF-a on cytochrome c oxidase activity. L929 cells were treated for 72 h with
TNF-a (25 ng/ml). Cells were then placed in an oxygen electrode cuvette. Oxygen consumption
was measured using ascorbate/TMPD as the electron donor. (B) Effect of TNF-a on lactate
production. L929 cells were treated for 72 h with TNF-a (25 ng/ml) and lactate concentration
was determined in the medium samples as described in the Experimental section. (C) Effect
of TNF-a on glucose consumption. L929 cells were treated for 72 h with TNF-a (25 ng/ml)
and glucose concentration, at the indicated times, was determined in the medium from control
(+) and TNF-a-treated (_) cells as described in the Experimental section. Values are given
as means‡S.D. from three independent experiments. *P ! 0.001 between control and
experimental cells.
induced a significant decrease in the protein levels of ATPase
subunit a and COX II, both of which are encoded by the mtDNA
(Figure 6). In contrast, mitochondrial proteins encoded by the
nucleus, such as cytochrome c oxidase, subunit IV, ubiquinol-
cytochrome c oxidoreductase subunit core 2, ATPase subunit a
and cytochrome c, were unaltered. These results suggest that
TNF-a treatment affects mitochondria by down-regulating the
expression levels of proteins encoded by the mtDNA. To verify
the functional significance of the increased mRNA steady-state
levels of key glycolytic enzymes at the protein level, we also
performed Western blot analysis of cytosolic fractions from
control and TNF-a-treated L929 cells (Figure 7). TNF-a induced
a significant increase in the protein levels of PFK, whereas the
levels of GAPDH were unaltered. These results were confirmed
by measuring the enzymic activity for both proteins in whole-cell
lysates (results not shown). Furthermore, the protein levels of
MnSOD, a mitochondrial protein involved in antioxidant defence
and encoded by the nucleus, were increased after TNF-a treat-
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A
B
Figure 9 Effects of TNF-a on the catabolic function of the TCA cycle
(A) Effect of TNF-a intracellular metabolic intermediates. Cellular extract from L929 cells treated
with TNF-a (25 ng/ml) for 72 h were subjected to 1H-NMR analysis as is described in the
Experimental section. Results are expressed as the means‡S.D. of the ratio TNF-a/control
values of three independent experiments. (B) Effect of TNF-a on glutamine oxidation. L929 cells
were treated for 72 h with TNF-a (25 ng/ml). Cells were then incubated for 3 h with 0.5 lCi
of L-[U-14C]glutamine and the radioactive CO2 release was trapped and measured as is
described in the Experimental section. Values are given as means‡S.D. from three
independent experiments. Results are expressed as c.p.m./106 cells. *P ! 0.001 between
control and treated cells.
ment, indicating that TNF-a also triggers the induction of
protective mechanisms against ROS.
Mitochondrial dysfunction and shift from oxidative phosphorylation
to glycolysis
To determine mitochondrial dysfunction and the compensatory
glycolytic pathway shift under TNF-a treatment, we measured
cytochrome c oxidase activity, lactate production and glucose
consumption in control and TNF-a-treated cells for 72 h.
TNF-a induced a significant decrease in cytochrome c oxidase
activity and a substantial increase in lactate production and
glucose consumption (Figure 8). These results confirmed that
mitochondrial dysfunction led to a compensatory increase in the
glycolytic flux in L929 cells. To further analyse the metabolic
alterations induced by TNF, we performed "H-NMR analysis of
cellular extracts from L929 cells treated with TNF for 72 h. We
observed that TNF-a induced the intracellular accumulation of
lactate, acetate and several metabolic intermediates from the
tricarboxylic acid (TCA) cycle such as fumarate and succinate
(Figure 9A). To confirm the TCA cycle dysfunction at this time,
A
B
C
Figure 10 Effects of antioxidants on TNF-a-mediated oxidative stress
(A) Effect of the antioxidants BHA and BHT on TNF-a-induced cytotocicity and ROS formation.
L929 cells were treated for 72 h with TNF-a (25 ng/ml). BHA (40 lM) or BHT (100 lM) was
added at the same time as TNF-a. Cell viability was examined by flow cytometry and PI staining.
Cellular generation of ROS was determined by flow cytometry using R123 fluorescence.
*P ! 0.001 between control and treated cells ; aP ! 0.001 and bP ! 0.01 between TNF-a
and TNF-a/BHA or TNF-a/BHT respectively. (B) Effect of the antioxidants BHA and BHT on
TNF-a-induced down-regulation of the mitochondrial transcript ATPase 6-8. Total RNA (10 lg/
lane) isolated from control and TNF-a-treated (25 ng/ml) L929 cells for 72 h in the absence
or presence of BHA (40 lM) or BHT (100 lM), was analysed by Northern hybridization using
a radiolabelled ATPase 6-8 probe. RNA loading and integrity was assessed by probing with
18 S rDNA. (C) Effect of the antioxidants BHA and BHT on TNF-a-induced down-regulation
of mitochondrial protein levels. Proteins from mitochondrial extracts of L929 cells exposed to
TNF-a (25 ng/ml) in the presence or absence of BHA or BHT were separated by SDS/PAGE
(10% gel) and immunostained with antibodies against ATPase subunits a and a, and
COX II.
we also measured glutamine oxidation in control and TNF-a-
treated cells for 72 h. As is shown in Figure 9(B), glutamine
oxidation was significantly decreased in TNF-a-treated cells,
suggesting a blockade of the TCA cycle.
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Although substantial changes in mitochondria function were
observed after 72 h of TNF-a treatment, no significant change
in ATP content was observed in TNF-a-treated cells compared
with that of the control cells (8.0‡1.45 versus 8.40‡1.6 nmol}
10’ cells), suggesting that the compensatory increase in the
glycolytic flux was able to maintain cellular ATP levels in
the majority of living cells.
Antioxidants blocked the decrease in ATP 6-8 mRNA levels
To further examine the role of ROS generation in both the
TNF-a-induced cytotoxicity, and down-regulation of mito-
chondrial transcripts and proteins, we treated the cells with
TNF-a in the presence of two antioxidants, BHA and BHT, and
examined the rate of cell death, ROS levels, steady-state levels of
ATPase 6-8 mRNA and protein levels of several mitochondrial
proteins. Both antioxidants attenuated cell death, blocked ROS
generation, prevented the down-regulation of the mitochondrial
transcript ATPase 6-8 and preserved the protein levels of both
ATPase subunit a and COX II (Figure 10). These results suggest
that TNF-a-induced ROS production in L929 cells may
be involved in the down-regulation of mtDNA transcription
or mitochondrial mRNA stability, the reduced expression level of
mitochondrial proteins encoded by mtDNA and in cell death. To
further support the role of ROS formation and ATPase 6-8
down-regulation in TNF-a-induced cytotoxicity, we followed the
kinetics of both phenomena in human MRC-5 fibroblasts and rat
hepatic stellate cells, two TNF-a-resistant cell lines. In these cells,
neither ROS production nor ATPase 6-8 down-regulation was
observed (results not shown), suggesting their connection with
TNF-a cytotoxicity.
DISCUSSION
To explain the mechanism of TNF cytotoxicity, we studied the
pathological changes induced by this cytokine in L929 cells and
the protective mechanism activated by the cells to survive.
First, we showed that TNF-a-induced necrosis in L929 cells
was associated with increased ROS production and decreased
glutathione levels. These results are in agreement with numerous
studies that have previously reported that TNF-a induces ROS
production, presumably at the mitochondrial level [7–9,41]. The
observation that mitochondria are the main source of ROS in
TNF-a cytotoxicity also suggests that mitochondrial components
may be especially sensitive to oxidative damage. However, the
real target of the ROS effect remains unclear. Several studies
have shown that mitochondrial RNAs undergo specific degra-
dation in differentmodels of oxidative stress. Following treatment
of hamster fibroblasts with H
#
O
#
, Crawford et al. [27] observed
that the 16 S rRNA, a major component of mitochondrial
ribosomes, was specifically degraded whereas cytosolic mRNA
was not. This resulted in a dramatic shutdown of mitochondrial
protein biosynthesis. A similar observation was reported in a
human megakaryocyte cell line, where endogenous H
#
O
#
leads to
a decrease in mitochondrial RNA levels [42]. In addition,
oxidative stress caused by H
#
O
#
treatment, catalase knock-out or
aging has been reported to be closely associated with reductions
in mitochondrial transcripts and contributes to mitochondrial
dysfunction in Drosophila melanogaster [43,44]. Consistent with
these results, we demonstrated that TNF-a induced a down-
regulation of the mitochondrial transcript ATPase 6-8 and other
mitochondrial transcripts detected by the pAM I probe. This
alteration at the RNA level was associated with a decrease in
protein levels of the ATPase subunit a, which is encoded by the
bicistronic mRNA ATPase 6-8. Furthermore, TNF induced a
down-regulation of protein levels of other mitochondrial proteins
encoded by the mtDNA, such as COX II. Together, these results
suggest that TNF-a had a general effect on the steady-state levels
of mitochondrial transcripts and mtDNA-encoded proteins. The
F
"
F
!
-ATPase or F
"
F
!
-ATP synthase is the key enzyme for ATP
production in mammals [45]. It catalyses ADP phosphorylation
using an electrochemical proton gradient generated by the
mitochondrial electron-transport chain [46]. It is a ubiquitous,
highly conserved enzyme composed by two main sectors : F
!
,
which is membrane-embedded and comprises 10 different sub-
units, and F
"
, which is an extrinsic-membrane catalytic sector
containing five subunits. All components are required to obtain
functional ATP synthase. A large body of evidence supports the
notion that reversible ATP synthesis coupled to a proton flux
across F
!
is mediated by conformational changes transmitted
from the membrane sector to the catalytic sector of the F
!
F
"
complex. The ATPase subunit a protein is a component of sector
F
!
. The subunits of F
!
together provide the proton-conduction
pathway and mutagenesis studies have indicated that ATPase
subunit a is important for proton transport [47]. ATPase sub-
unit a down-regulation should therefore invariably slow down
mitochondrial ATP synthesis and block or slow down the
intermediary metabolism.
As the terminal component of the mitochondrial respiratory
chain, cytochrome c oxidase catalyses the transfer of electrons
from reduced cytochrome c to molecular oxygen and utilizes the
free energy of this reaction to sustain a transmembrane proton
gradient which is then used to drive the synthesis of ATP or ion
transport [48]. Mammalian cytochrome c oxidase contains a
total of 10 nuclear-encoded and three mitochondrially encoded
polypeptide subunits. Subunits I (COX I) and II (COX II) are the
catalytic core of the enzyme. Subunit III and most of the nuclear
subunits are essential for the assembly of a functional catalytic
enzyme [49]. Thus the reduced protein levels of COX II and
ATPase subunit a may have important functional consequences
and would explain the mitochondrial dysfunction induced by
TNF-a, which has been characterized in many reports [7,9,50]. In
fact, we demonstrated that TNF-a treatment induced a significant
reduction in cytochrome c oxidase activity and glutamine oxi-
dation, indicating that the normal electron flux in mitochondria
is altered. However, despite significant changes in mitochondria
function were observed in TNF-treated cells, the cellular ATP
content did not change significantly, which may be explained by
the adaptive changes in the energy-generation mechanism acti-
vated in these cells. When the reduced oxidative ability caused by
TNF-a treatment cannot meet the cellular requirements for
energy, up-regulation of glycolysis may occur, as demonstrated
previously in different experimental models [51]. Indeed, we
observed a shift from oxidative phosphorylation to glycolysis in
TNF-a-treated cells, as demonstrated by significantly increased
lactate production and glucose consumption in these cells.
Supporting this hypothesis, we demonstrated that simultaneously
to mitochondrial mRNA and protein down-regulation, TNF-a
also induced an up-regulation of the steady-state mRNA levels
for GAPDH and PFK. This increase was associated with
increased protein levels of PFK, a key enzyme in glycolysis.
Taken together these observations suggest that L929 cells attempt
to compensate for the TNF-a-induced down-regulation of mito-
chondrial gene and protein expression by stimulating the ex-
pression of glycolytic enzymes, and thus, increasing the glycolytic
flux.
There are three possibilities to explain the down-regulation
of the mitochondrial transcripts : (i) reduced gene dosage,
(ii) reduced transcription rate and (iii) increased degradation of
mitochondrial transcripts. We showed that TNF-a had no effect
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on mtDNA content, suggesting that reduced gene dosage is
probably not the cause of mitochondrial mRNA down-
regulation. Furthermore, the absence of smearing of the bands
suggested that the decrease in the mitochondrial mRNA levels is
probably due to a reduced transcription rate and not degradation.
Several reports have implicated ROS production in TNF-a-
induced cytotoxicity on the basis of the protective effects exerted
by radical scavengers [7,9]. We show here that the radical
scavengers BHA and BHT blocked the production of free
radicals, prevented the down-regulation of ATPase 6-8 tran-
scripts, preserved the protein levels of ATPase subunit a and
COX II, and attenuated the cytotoxic response to TNF-a,
suggesting a direct link between these alterations.
In summary, we have shown that TNF-a-induced necrosis in
L929 was associated with ROS production, down-regulation of
mitochondrial transcripts and reduced protein levels of the
ATPase subunit a and COX II, both mitochondrial proteins
encoded by mtDNA. Functionally, cytochrome c oxidase activity
and glutamine oxidation was decreased. Simultaneously, the cells
promoted compensatory and protective mechanisms, such as
induction of MnSOD and up-regulation of glycolytic enzymes at
both the RNA and protein levels, accompanied by an increased
glycolytic flux. The antioxidants BHA and BHT blocked the
production of free radicals, prevented the down-regulation of
ATPase 6-8 transcripts and ATPase subunit a expression levels,
and attenuated the cytotoxic response to TNF-a, suggesting a
direct relationship between these phenomena. According to this
scheme, TNF-a-induced ROS production could be sufficient to
override cell antioxidant defences and lead to cell death by down-
regulating key components of the mitochondrial oxidative
phosphorylation, consequently provoking a bioenergetic collapse
if a sufficient glycolytic compensatory increase is not activated.
Alternatively, the intracellular accumulation of lactate and other
TCA cycle intermediates due to efficient compensatory glycolysis
could alter cellular osmotic and pH homoeostasis and induce,
eventually, plasma membrane permeabilization. In both hypoth-
eses, the balance between pathological changes and protective
mechanisms seems to be essential to decide the fate of cells.
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